Prof Peter-Phillip de Cruz
Professorial Fellow, Gastroenterology
Department of Medicine
390 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
2026
Journal article
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn’s Disease Postoperative Recurrence in the PREVENT Trial
DOI: 10.1016/j.cgh.2025.08.0212024
Research grants (ARC, NHMRC, MRFF)
Mathematical and Computational Methods for Precision Medicine in Acute Severe Ulcerative Colitis
2022
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes in Inflammatory Bowel Disease: A Multifaceted Program of Research
2021
Research grants (ARC, NHMRC, MRFF)
A Prospective Randomised Controlled Trial of Adults With Perianal Fistulising Crohn\2019s Disease and Optimised Therapeutic Infliximab Levels: PROACTIVE Trial
2016
Journal article
Intestinal Failure and Transplant: The Australian Experience (2009 to 2014)
DOI: 10.1016/j.transproceed.2015.09.0712015
Journal article
Crohn's disease management after intestinal resection: A randomised trial
DOI: 10.1016/S0140-6736(14)61908-5
RECENT SCHOLARLY WORKS
2026
Journal article
980 RANDOMISED CONTROLLED TRIAL OF CONTINUED INTRAVENOUS VERSUS SWITCHING TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: THE SUBCUTANEOUS INFLIXIMAB SWITCH STUDY (SISS).
DOI: 10.1016/s0016-5107(26)02347-32026
Journal article
Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study
DOI: 10.1002/jgh3.704102026
Journal article
980 RANDOMISED CONTROLLED TRIAL OF CONTINUED INTRAVENOUS VERSUS SWITCHING TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: THE SUBCUTANEOUS INFLIXIMAB SWITCH STUDY (SISS).
DOI: 10.1016/s0016-5085(26)02416-92026
Journal article
2026
Journal article
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.
DOI: 10.1093/ibd/izag0422026
Journal article
Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review.
DOI: 10.1093/ibd/izag0642026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202026
Journal article
Implementation of values-based healthcare in inflammatory bowel disease—a review
DOI: 10.1093/ecco-jcc/jjaf173